The global cardiac rhythm management devices market is projected to reach USD 41.67 Billion by 2028 at a CAGR of 7.0% during the forecast period. The demand cardiac rhythm management devices have been increasing with increasing heart disorders across various age groups, changing lifestyles among the population. Major functions performed by cardiac rhythm management devices include bradycardia pacing,  cardiac resynchronization for heart failure, monitoring for arrhythmias, defibrillation and anti-tachycardia pacing for tachyarrhythmias. The cardiac rhythm management devices market by type is segmented by defibrillators, cardiac resynchronization therapy devices, and pacemakers. Defibrillators among these segments dominated the market followed by pacemakers. On the basis of the end user, the market is segmented by hospitals, ambulatory care, and home care. The increasing use of these devices in ambulatory care and home care is expected to drive the demand during the forecast period.

Global Cardiac Rhythm Management Device Market

The cardiac rhythm management devices market by region is segmented by North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, and Rest of the World. North America estimated to dominate the market during the forecast period.

Some of the key Impact Factors:

  • Increasing heart disorders across various age groups
  • Increasing demand from ambulatory care and home care
  • Increasing expenditures from the government on the healthcare sector

What does this report provide?

This report provides a detailed understanding of the cardiac rhythm management devices market from a qualitative and quantitative perspective with a forecast of 10 years. The report also provides dynamic indicators with potential impact on the market during the forecast period and in-depth analysis of the leading companies operating in the market. 

Market Segmentation: 

By Type:

  • Defibrillator
  • Cardiac Resynchronization Therapy Devices
  • Pacemakers

By End User:

  • Hospitals
  • Ambulatory Care
  • Home Care

By Region:

  • North America
    • By Country (US, Canada, Mexico)
    • By Type
    • By End User
  • Western Europe
    • By Country (Germany, UK, France, Italy, Spain, Rest of Western Europe)
    • By Type
    • By End User
  • Eastern Europe
    • By Country (Russia, Turkey, Rest of Eastern Europe)
    • By Type
    • By End User
  • Asia Pacific
    • By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
    • By Type
    • By End User
  • Middle East
    • By Country (UAE, Saudi Arabia, Qatar, Iran, Rest of Middle East)
    • By Type
    • By End User
  • Rest of the World
    • By Region (South America, Africa)
    • By Type
    • By End User

Companies Covered: Abiomed, Koninklijke Philips N.V., Boston Scientific Corporation, Medtronic plc., Abbott Laboratories, Biotronik Se Co Kg, Cardiac Science Corporation, LivaNova Plc, Zoll Medical Corporation, Schiller Ag,  and others…

Reasons to buy this report:

  • Market size estimation of cardiac rhythm management devices market on a regional and global basis
  • The unique research design for market size estimation and forecasts
  • Profiling of the major companies operating in the market with key developments
  • Broad scope to cover all the possible segments helping every stakeholder in the market


We provide customization of the study to meet the specific requirements:

  • By segment
  • By sub-segment
  • By region/ country

For more information, contact:

License Offerings

Single User License - USD 3999

Multi User License - USD 5499

Corporate License - USD 6999

Why QMI?

Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision


Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements

Related Insights:
Close Menu